Longeveron (LGVN) Non-Current Assets (2021 - 2026)

Longeveron's (LGVN) quarterly Non-Current Assets came in at $4.4 million in Q1 2026, down 21.86% year-on-year from $5.6 million in Q1 2025, and down 9.46% quarter-over-quarter from $4.8 million in Q4 2025.

Longeveron (LGVN) Non-Current Assets (2021 - 2026) Analysis & Trends

Longeveron's Non-Current Assets history runs 6 years deep, the most recent figure standing at $4.4 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 21.86% year-over-year to $4.4 million in Q1 2026; TTM through Mar 2026 was $19.9 million, a 15.95% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, down 18.94% from the prior year.
  • Non-Current Assets eased to $4.4 million in Q1 2026 per LGVN's latest filing, from $4.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $7.1 million in Q4 2022 and bottomed at $4.4 million in Q1 2026.
  • The 5-year median for Non-Current Assets is $6.0 million (2024), against an average of $5.9 million.
  • Across the five-year window, Non-Current Assets slipped 3.43% in 2022 and fell 21.86% in 2026, its largest moves.
  • Year by year, Non-Current Assets stood at $7.1 million in 2022, then dropped by 12.66% to $6.2 million in 2023, then dropped by 4.75% to $5.9 million in 2024, then dropped by 18.94% to $4.8 million in 2025, then slipped by 9.46% to $4.4 million in 2026.
  • Per Business Quant, the three latest LGVN Non-Current Assets figures stand at $4.4 million (Q1 2026), $4.8 million (Q4 2025), and $5.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Longeveron 3.97 Mn -11.79 Mn 264,000.00 4.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.36 Mn
Dec 31, 2025 4.81 Mn
Sep 30, 2025 5.22 Mn
Jun 30, 2025 5.48 Mn
Mar 31, 2025 5.57 Mn
Dec 31, 2024 5.93 Mn
Sep 30, 2024 6.14 Mn
Jun 30, 2024 5.98 Mn
Mar 31, 2024 5.94 Mn
Dec 31, 2023 6.23 Mn
Sep 30, 2023 6.58 Mn
Jun 30, 2023 6.80 Mn
Mar 31, 2023 6.94 Mn
Dec 31, 2022 7.13 Mn
Dec 31, 2021 7.39 Mn